Bisomni — Bisoprolol Fumarate IP 2

Bisomni is a pharmaceutical product manufactured and marketed by EMK Omni Pharma, a trusted pharmaceutical company based in Mysuru, Karnataka. It belongs to the Blood Pressure Management therapeutic category and is available as a Tablet formulation.

BISOMNI 2.5 by EMK Omni Pharma is a prescription-based Bisoprolol Fumarate Tablets IP formulation used for doctor-supervised blood pressure management, heart rate control, and cardiovascular health support. Each film-coated tablet contains Bisoprolol Fumarate IP 2.5 mg. BISOMNI 2.5 belongs to the beta-blocker category of medicines and is commonly prescribed by healthcare professionals for patients who require support in managing hypertension, high blood pressure, cardiac workload, and heart-related health conditions. BISOMNI 2.5 Bisoprolol Fumarate 2.5 mg Tablets by EMK Omni Pharma are designed for patients who need physician-guided treatment for blood pressure control, heart care, cardiovascular risk management, and long-term cardiac support. This medicine should be taken only as advised by a registered medical practitioner.

Each tablet of Bisomni contains the following active pharmaceutical ingredients:

Active Composition: Bisoprolol Fumarate IP 2

Dosage Strength: 2.5 mg

Medicine Type: Tablet

Pack Size: 10 X 10 Tablets

The formulation is prepared with approved excipients to ensure optimal stability, bioavailability, and therapeutic efficacy. All ingredients comply with Indian Pharmacopoeia (IP) standards where applicable.

Bisomni is classified under the Blood Pressure Management therapeutic category. This category encompasses medicines that are commonly prescribed by healthcare professionals for conditions related to hypertension, blood pressure control, heart rate regulation, cardiac workload reduction, and vascular health.

BISOMNI 2.5 may be prescribed by doctors for patients who require support in managing high blood pressure, hypertension, elevated heart rate, cardiac strain, and cardiovascular health concerns. It may be used as part of a complete physician-guided heart care plan for individuals with blood pressure-related health risks or long-term cardiac management needs. BISOMNI 2.5 by EMK Omni Pharma is suitable for doctor-supervised treatment where blood pressure control, heart rate regulation, and cardiovascular support are required. Patients should not self-medicate, change the dosage, stop the medicine suddenly, or combine it with other medicines without consulting their doctor.

Bisomni is formulated as a Tablet with a dosage strength of 2.5 mg. It is available in a pack size of 10 X 10 Tablets.

This product is designed for oral administration and should be taken exactly as prescribed by a registered medical practitioner. Patients should not alter the dosage, crush, chew, or break the tablet unless specifically instructed by their physician.

Important: The dosage and duration of treatment are determined by the prescribing physician based on the patient's individual medical condition, age, weight, and response to treatment.

Proper storage of pharmaceutical products is essential to maintain their quality, potency, and safety. Bisomni should be stored according to the following guidelines:

BISOMNI 2.5 Bisoprolol Fumarate Tablets IP should be stored in a cool, dark, and dry place below 25°C.

General Storage Guidelines:

• Keep the medicine in its original packaging until use
• Do not use the medicine after the expiry date printed on the packaging
• Do not store in the bathroom or near a sink
• Protect from direct sunlight, heat, and humidity
• Keep out of reach of children and pets

Bisomni is a prescription-based pharmaceutical product. It must only be dispensed and used under the guidance of a registered medical practitioner.

Prescription Warning: This is a prescription-based medicine. Use only as directed by a registered medical practitioner.

This medicine is regulated under Indian pharmaceutical laws and is subject to Schedule H / Schedule G drug regulations as applicable. It should not be purchased or used without a valid prescription from a licensed healthcare professional.

For Healthcare Professionals: Bisomni is available through authorised pharmaceutical distribution channels. For product availability, pricing, and distribution enquiries, please contact EMK Omni Pharma directly.

Caution Details: The product should be protected from light, heat, and moisture, and must be kept out of reach of children.

General Safety Information:

• Do not self-medicate. Always consult a qualified healthcare professional before starting any new medication.
• Inform your doctor about all other medicines, supplements, or herbal products you are currently taking to avoid potential drug interactions.
• If you experience any unexpected side effects or adverse reactions, stop taking the medicine and consult your physician immediately.
• Do not share this medicine with others, even if they have similar symptoms.
• Follow the complete course of treatment as prescribed by your doctor.
• Pregnant or breastfeeding women should consult their physician before using this medicine.
• This medicine is not recommended for use in children unless specifically prescribed by a paediatrician.

EMK Omni Pharma is a trusted pharmaceutical company based in Mysuru, Karnataka, operating as Under the visionary leadership of Kumara Swamy, the company is committed to providing high-quality, physician-guided pharmaceutical products across multiple therapeutic areas.

Our product portfolio includes medicines for Cardiac Care, Cholesterol & Lipid Care, Blood Pressure Management, Nutritional Supplements, Pain Management, and Diabetes Care, all formulated to meet established pharmaceutical quality standards. EMK Omni Pharma works closely with healthcare professionals, pharmacies, hospitals, and distribution partners to ensure that quality medicines reach those who need them — safely, reliably, and responsibly.

Office Address: 2nd Floor, Room No. 01, 102A, Panchamantra Rd, above Kumar Medicals, Kuvempu Nagara, Mysuru, Karnataka 570023

Email: info@emkomnipharma.com

The information provided on this page is intended for general educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations.

This product information should not be used as a substitute for professional medical advice. Always consult a qualified and registered medical practitioner before starting, stopping, or changing any medication. Self-medication can be harmful and may lead to serious health consequences.

EMK Omni Pharma does not make any therapeutic claims about curing, treating, or preventing any disease without proper clinical evidence and regulatory approval. All products are intended for use only under proper medical supervision.

The product details, composition, and usage guidelines mentioned here are based on the manufacturer's product information and are subject to change. For the most current product information, please refer to the actual product packaging or consult your healthcare provider.